By enhancing feelings of fullness, delaying stomach emptying, and helping control blood sugar, Semaglutide reduces hunger and calorie intake
Unlike prior reports of fasting beyond 21 days in non-obese individuals [11, 12], this case demonstrates substantial weight loss (125 pounds) accompanied by improvements in depression, anemia, hypoxia/hypercapnia, functional status, and left ventricular (LV) mass
Hyperactivity (28%) was identified in a study of 14 individuals with ARTHS and autism-like behaviours (28%) confirmed, including reduced social awareness, social cognition, and social communication, as well as restricted interests and repetitive behaviours (Ng et al, 2024)
Patients should be counseled about gastrointestinal side effects and the importance of gradual dose titration